In final draft guidance published today we've confirmed that we’re unable to recommend cerliponase alfa (also called Brineura and made by BioMarin) for routine NHS use in treating neuronal ceroid ...

Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...

Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

Hundreds of adults and teenagers in England with a rare, inherited eye disease will benefit from a new treatment after NICE today recommended idebenone for visual impairment caused by Leber's ...

The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...

See a complete list of all our guidance and quality standards currently open for consultation ...

NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.

May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COPD see our guideline on diagnosing ...

Questions to ask about mental health problems in pregnancy and the year after birth These questions may help you discuss your condition or the treatments you have been offered with healthcare ...

View a complete list of all our guidance, NICE advice and quality standards currently in development ...

NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England. People ...

Older people All NICE products on older people. Includes any guidance, advice and quality standards. Published products on this topic (21) ...